Comments (5) | Add a comment
Companies appeal verdict in hepatitis lawsuit
Tools
LAS VEGAS REVIEW-JOURNAL
The lawyers for two drug companies that came out on the losing end of a half-billion-dollar verdict in the first trial related to the valley’s hepatitis outbreak want the judge who heard the case to block the award.
“On May 7, 2010, plaintiffs were awarded a $500 million jury verdict on punitive damages that is grossly excessive, unsupported by the evidence, and in violation of defendants’ due process rights,” Mark E. Tully and U. Gwyn Williams of Boston wrote in court papers.
Opposing attorney Robert Eglet replied that the “defendants’ hyperbole that this is an ‘astronomical’ punitive damages award should be recognized as blatant fear mongering designed to distract this court from the simple issues before it.”
Eglet represented plaintiff Henry Chanin, who contracted hepatitis C after undergoing a colonoscopy four years ago this month at one of three now bankrupt clinics run by Dr. Dipak Desai, who recently was named in a 28-count criminal indictment.
A jury awarded Chanin, the headmaster at The Meadows school in Las Vegas, and his wife, Lorraine, a combined $505 million verdict in both compensatory and punitive damages.
The jury put Teva Parenteral Medicines Inc. on the hook for $356 million, and co-defendant Baxter Healthcare Corp. was liable for $144 million in punitive damages. Teva manufactured the sedative propofol, and Baxter distributed the drug.
The crux of the lawsuit was that the companies sold inadequately labeled 50-milliliter vials of the drug to small clinics despite evidence that the large vials were being used on multiple patients. Eglet in his opposition said Teva and Baxter were aware of at least 148 prior cases elsewhere in the United States of infection because of misuse and did nothing.
Tully in court papers said the Supreme Court of the United States “has held that grossly excessive or arbitrary punitive damages awards are violative of a defendant’s due process rights” and established three guideposts to help judges determine the constitutionality of such awards. They include consideration of the reprehensibility of the defendant’s conduct; the ratio of the punitive damages award to the actual harm inflicted on the plaintiff; and how the award compares with similar cases.
Tully in court papers asked district Judge Jessie Walsh to reduce the award to a “single digit” ratio over the $5 million compensatory award the jury granted. He argued the U.S. Supreme Court has said any punitive damages awards in excess of four times the compensatory award “might be close to the line of constitutional impropriety.”
Eglet disagreed, saying the defendants misrepresented how the jury arrived at the figure. When properly calculated, he argued, the ratio is 27 times for Teva and 11 times for Baxter.
Nevada law exempts product liability judgments from a cap on damages.
The defendants and critics of the jury award question the relationship between Eglet’s law firm, Mainor Eglet Cottle, and Walsh. Records show that firm and its attorneys contributed $40,000 to her 2008 judicial campaign. Eglet said the contributions are a “red herring” designed to discredit “a fine judge.”
Walsh was not assigned the case until late 2009, and not until the plaintiffs and defendants each objected to other judges being assigned the case.
Regarding the punitive damages awarded to the Chanins, Tully suggests $5 million is closer to being reasonable than is $500 million. Eglet countered by arguing the defense ignored a key factor in the judgment, the reprehensible conduct of the defendants.
Contact Doug McMurdo at dmcmurdo@reviewjournal.com or 702-224-5512 or read more courts coverage at lvlegalnews.com.
Comments
Terms & Conditions
The following comments are provided by readers and are the sole responsiblity of the authors. The Review-Journal does not review comments before publication nor guarantee their accuracy. By publishing a comment here you agree to abide by the comment policy. If you see a comment that violates the policy, please use the Report Abuse button.
Some comments may not display immediately due to an automatic filter. These comments will be reviewed within 24 hours. Please do not submit a comment more than once.
Note: Comments made by reporters and editors of the Las Vegas Review-Journal are presented with a yellow background.
RSS
Twitter
Facebook
anything less than the award granted by the jury would be a slap on the wrist. The award isn't about the plaintiff, it's about punishment for the drug companies whose combined profits last year were 13.5 billion. half a billion isn't even a two week penalty and is easily justifiable. What most of you may not know is there are many other cases scheduled for court that will be identical to the Chanin case. Same drug companies, same circumstances, same clinic, sometimes even the same plaintiff's attorneys. Teva and Baxter need to settle those cases if they don't expect to see this happening over and over during the next couple years.
Both the judge and the jury were derelict in performing their duties.
To penalize the drug provider is completely asinine.
Good for the drug companies. I was treated at that center during that time and also had to get tested. Had I come up positive I would have never dreamed of sueing the drug company. The fact that someone actually allowed them to be sued is just wrong. Are you going to tell me that if someone gets behind the wheel of their Toyota and runs someone over we can now sue Toyota for wrongful use of their product? What has this country come to? The bottom line is, no matter how these products were packaged and sold, the ones using them were supposed to be professionals and should have known better. Shame on the Doctors & Nurses at the Endoscopy Center, they got greedy and didn't follow proper protocol, they are the ones to blame. And shame on the money grubbing laywer that filed the law suit, you are everything that is wrong with the judicial system. Twisting laws and finding loop holes to get what you want. Sorry to the victims in this but I personally hope the drug companies get off without paying a dime, they are not at fault.
We all knew it wouldn't take long for the appeal to come. I too agree that $500 million is way too much!
All Eglet's comment means to me, is that in 148 other cases..some idiot reused needles and did the exact same thing Desai and his staff did.
Still not the drug companies fault, I don't care which way he wants to spin it.
The jury only awarded this number because is the example he gave in jury selection..I doubt they came up with it on their own.